3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
7
Neurofibromatosis 1
6
Neoplasm Metastasis
6
Solid Tumours
5
Neoplasms
5
Melanoma
5
Neurofibroma, Plexiform
4
Lung Neoplasms
3
Colorectal Neoplasms
3
Breast Neoplasms
2
Biliary Tract Neoplasms
2
Uveal Melanoma
1
Solid Tumors
1
Renal Insufficiency
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Muscle Invasive Bladder Cancer
1
Locally Advanced or Metastatic Solid Tumors
1
Kidney Neoplasms
1
Healthy Volunteers Pharmacokinetic Study
1
Disease Progression
1
Differentiated Thyroid Cancer
1
Colonic Neoplasms
1
Advanced Non Small Cell Lung Cancer
1
Advanced Cancer
1
Interventions
vistusertib
1
tislelizumab
1
olaparib
1
durvalumab
1
danvatirsen
1
adavosertib
1
AZD4547
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Muscle Invasive Bladder Cancer
×
AZD 6244
×
Clear all
NCT02546661
2025-12-29
BISCAY
AstraZeneca
Phase 1
Active not recruiting
117 enrolled